Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
11.51
+0.72 (6.67%)
At close: Apr 28, 2026, 4:00 PM EDT
11.73
+0.22 (1.91%)
After-hours: Apr 28, 2026, 7:04 PM EDT
Prothena Corporation Employees
Prothena Corporation had 67 employees as of December 31, 2025. The number of employees decreased by 96 or -58.90% compared to the previous year.
Employees
67
Change (1Y)
-96
Growth (1Y)
-58.90%
Revenue / Employee
$144,537
Profits / Employee
-$3,643,164
Market Cap
619.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Arvinas | 246 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Prime Medicine | 146 |
| Sutro Biopharma | 137 |
| Alpha Tau Medical | 121 |
| Ocugen | 116 |
| Aclaris Therapeutics | 73 |
PRTA News
- 1 day ago - Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy - Business Wire
- 18 days ago - Prothena Announces Leadership Team Updates - Business Wire
- 5 weeks ago - Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD™ 2026 - Business Wire
- 6 weeks ago - Prothena Corporation Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy - Business Wire
- 2 months ago - Prothena Announces up to $100 Million Share Repurchase Plan - Business Wire
- 2 months ago - Prothena Corporation Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire